Mapping the progress of Alzheimerś and Parkinsonś disease: [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan]
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Kluwer Academic/Plenum Publ.
2002
|
| Schriftenreihe: | Advances in behavioral biology
51 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XXII, 565 S. Ill., graph. Darst. |
| ISBN: | 0306467631 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV014760651 | ||
| 003 | DE-604 | ||
| 005 | 20030506 | ||
| 007 | t | ||
| 008 | 020926s2002 ad|| |||| 10||| eng d | ||
| 020 | |a 0306467631 |9 0-306-46763-1 | ||
| 035 | |a (OCoLC)248474500 | ||
| 035 | |a (DE-599)BVBBV014760651 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-12 | ||
| 050 | 0 | |a RC523 | |
| 082 | 0 | |a 616.831 | |
| 084 | |a YG 4005 |0 (DE-625)153494:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Mapping the progress of Alzheimerś and Parkinsonś disease |b [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] |c ed. by Yoshikuno Mizuno ... |
| 264 | 1 | |a New York [u.a.] |b Kluwer Academic/Plenum Publ. |c 2002 | |
| 300 | |a XXII, 565 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Advances in behavioral biology |v 51 | |
| 650 | 4 | |a Alzheimer Disease |v Congresses | |
| 650 | 4 | |a Alzheimer's disease |v Congresses | |
| 650 | 4 | |a Parkinson Disease |v Congresses | |
| 650 | 4 | |a Parkinson's disease |v Congresses | |
| 650 | 0 | 7 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2001 |z Kioto |2 gnd-content | |
| 689 | 0 | 0 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Mizuno, Yoshikuni |e Sonstige |4 oth | |
| 830 | 0 | |a Advances in behavioral biology |v 51 |w (DE-604)BV000006474 |9 51 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009995095&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009995095 | ||
Datensatz im Suchindex
| _version_ | 1804129484764348416 |
|---|---|
| adam_text | CONTENTS
PROGRESS IN ALZHEIMERN DISEASE
ETIOLOGY AND PATHOGENESIS OF ALZHEIMERN DISEASE
CELL BIOLOGY OF AMYLOIDOGENESIS: AN OVERVIEW 1
Dennis J. Selkoe, Weiming Xia, W. Taylor Kimberly. Konstantinos Vekrellis.
Dominic Walsh, William Esler, and Michael S. Wolfe
ALZHEIMERN DISEASE AS A PROTEOLYTIC DISORDER:
CATABOLISM AND PROCESSING OF AMYLOID ß PEPTIDE 7
Nobuhisa Iwata and Takaomi C. Saido
AMYLOIDOGENESIS AND CHOLESTEROL 13
Katsuhiko Yanagisawa and Katsumi Matsuzaki
TOXICITY OF APP FRAGMENTS 19
Yoo Hun Suh, Ji Heui Seo, Yanji Xu. Chaejeong Heo. Najung Kim.
Jun Ho Choi, Se Hoon Choi, Jong Cheol Rah. Keun—A Chang.
and Won Hyuk Suh
SIGNIFICANCE OF NEUROFIBRILLARY TANGLES IN ALZHEIMERN
DISEASE—LESSONS FROM FRONTOTEMPORAL DEMENTIA
AND PARKINSONISM LINKED TO CHROMOSOME 17 27
Yasuo Ihara
THE EFFECTS OF APOLIPOPROTEIN E GENOTYPE ON BRAIN LIPID
METABOLISM 33
Alisa Tietz, Leah Oron. Eliezer Mazliah, and Daniel M. Michaelson
APOLIPOPROTEIN E: A NOVEL THERAPEUTIC TARGET FOR THE
TREATMENT OF ALZHEIMERN DISEASE 39
Judes Poirier and Michel Panisset
ANTISENSE INTERVENTION WITH CHOLINERGIC IMPAIRMENTS
ASSOCIATED WITH NELRODEGENERATIVE DISEASE 45
Eran Meshorer and Hermona E. Soreq
xiii
xi CONTENTS
NEURONAL SURVIVAL AND DEATH IN ALZHEIMER DISEASE 49
Arun K. Raina, Catherine A. Rottkamp, Xiongwei Zhu. Osama Ogawa.
Ayala Hochman, Shun Shimohama, Atsushi Takeda. Akihiko Nonomura,
George Perry. and Mark A. Smith
THE HISTAMINE CYTOKINE NETWORK IN ALZHEIMER DISEASE:
ETIOPATHOGENIC AND PHARMACOGENOMIC
IMPLICATIONS 59
Ramön Cacabelos
FAMILIAL ALZHEIMERN DISEASE AND BIOLOGY OF PRESENILINS
PRESENILIN AND AMYLOIDOGENESIS: A STRUCTURE FUNCTION
RELATIONSHIP STUDY ON PRESENILIN 2 65
Takeshi Iwatsubo, Taisuke Tomita, Tomonari Watabiki, Rie Takikawa,
Yuichi Morohashi, and Nobumasa Takasugi
PS1 INTERACTS WITH AND FACILITATES ß CATENIN TURNOVER 73
Edward H. Koo, Salvador Soriano, and David E. Kang
ß SECRETASE A TARGET FOR ALZHEIMERN DISEASE 79
Martin Citron
CELL BIOLOGY OF PRESENILINS 85
Seong Hun Kim and Sangram S. Sisodia
PRESENILIN DEPENDENT y SECRETASE PROCESSING OF ß AMYLOID
PRECURSOR PROTEIN AT A SITE CORRESPONDING TO THE
S3 CLEAVAGE OF NOTCH 91
Harald Steiner, Magdalena Sastre, Gerd Multhaup, David B. Teplow, and
Christian Haass
ENDOPLASMIC RETICULUM STRESS AND ALZHEIMERN DISEASE 95
Takashi Kudo, Taiichi Katayama, Kazunori Imaizumi, Yuka Yasuda,
Misako Yatera, Masayasu Okochi, Toshihisa Tanaka, Kojin Kamino,
Masaya Tohyama, and Masatoshi Takeda
PS 1 IS TRANSPORTED FROM THE MOTO NEURONS TO THEIR AXON
TERMINALS 101
Peter Kasa, Henrietta Papp, and Magdolna Pakaski
CALSENILIN PRESENILIN INTERACTION IN ALZHEIMERN DISEASE .. 105
Eun Kyoung Choi, Joseph D. Buxbaum, and Wilma Wasco
PRESENILIN 1 FUNCTION IN THE ADULT BRAIN 111
Jie Shen
CONTENTS xv
ANIMAL MODELS OF ALZHEIMER S DISEASE
NEUROPEPTIDE EXPRESSION IN ANIMAL DISEASE MODELS 117
Tomas Hökfelt, Margarita Diez, Tiejun Shi, Jari Koistinaho, Dora Games,
Karen Kahn, Bernd Sommer, Karl Heinz Wiederhold,
and Simone Danner
ROLE OF INDUCIBLE NITRIC OXIDE SYNTHASE IN ß AMYLOID
INDUCED BRAIN DYSFUNCTION IN RATS 121
Kiyofümi Yamada, Manh Hung Tran, Hyoung Chun Kim,
and Toshitaka Nabeshima
AMYLOID PATHOLOGY AND CHOLINERGIC NETWORKS IN
TRANSGENIC MODELS OF ALZHEIMER S DISEASE 127
A. Claudio Cuello
MECHANISM OF NEURONAL DEATH IN ALZHEIMER S DISEASE:
A TRANSGENIC MOUSE PERSPECTIVE 133
Michael C. Irizarry
INTERACTIONS OF BETA AMYLOID WITH THE FORMATION OF
NEUROFIBRILLARY TANGLES IN TRANSGENIC MICE 139
Jürgen Götz, Feng Chen, and Roger M. Nitsch
GLYCOSAMINOGLYCANS (GAGs) IN ALZHEIMER S DISEASE
HISTORICAL OVERVIEW OF GLYCOSAMINOGLYCANS (GAGs) AND
THEIR POTENTIAL VALUE IN THE TREATMENT OF
ALZHEIMER S DISEASE 145
U. Cornelli, I. Hanin, S. Lorens, J. Fareed, J. Lee, R. Mervis, P. Piccolo,
and M. Cornelli
GLYCOSAMINOGLYCANS AND GLYCOMIMETICS: POTENTIAL ROLE
IN THE MANAGEMENT OF ALZHEIMER S DISEASE 157
Qing Ma, Jawed Fareed, Bertalan Dudas, Umberto Cornelli, John Lee,
and Israel Hanin
LOW MOLECULAR WEIGHT GLYCOSAMINOGLYCAN BLOCKADE OF
BETA AMYLOID (25 35) INDUCED NEUROPATHOLOGY 165
M. Walzer, S. Lorens, M. Hejna, J. Fareed, R. Mervis, I. Hanin, U. Cornelli, and
J. M. Lee
C3, A PROMISING ULTRA LOW MOLECULAR WEIGHT
GLYCOSAMINOGLYCAN FOR THE TREATMENT OF
ALZHEIMER S DISEASE 171
Israel Hanin, Bertalan Dudas, Ronald F. Mervis, Umberto Cornelli, John M. Lee,
Stanley A. Lorens, and Jawed Fareed
xvj CONTENTS
CLINICAL EVALUATION OF ALZHEIMER S DISEASE
MILD COGNITIVE IMPAIRMENT 177
Vesna Jelic and Bengt Winblad
FUNCTIONAL ACTIVATION STUDIES IN ALZHEIMER PATIENTS AND
STRATEGIES IN DRUG EVALUATION 183
Agneta Nordberg
PROGRESS IN THE TREATMENT OF ALZHEIMER S DISEASE
STRUCTURAL AND FUNCTIONAL CORRELATES OF HUMAN
ACETYLCHOLINESTERASE MUTANTS FOR EVALUATING
ALZHEIMER S DISEASE TREATMENTS: FUNCTIONAL
ANALYSIS OF E2020 AND GALANTHAMINE HuAChE
COMPLEXES 187
Avigdor Shafferman, Dov Barak, Arie Ordentlich, Naomi Ariel,
Chanoch Kronman, Dana Kaplan, and Baruch Velan
THE NEW GENERATION OF ACETYLCHOLINESTERASE INHIBITORS.. 193
Hachiro Sugimoto, Yoichi Iimura, and Yoshiharu Yamanishi
TV3326, A NOVEL CHOLINESTERASE AND MAO INHIBITOR:
FOR ALZHEIMER S DISEASE WITH CO MORBIDITY
OF PARKINSON S DISEASE AND DEPRESSION 199
Marta Weinstock, Tatyana Poltyrev, Corina Bejar, Yotam Sagi,
and Moussa B. H. Youdim
NOVEL DRUG TREATMENT OF ALZHEIMER S DISEASE:
BEYOND CHOLINESTERASE INHIBITORS
Ml MUSCARINIC AGONISTS AS A THERAPEUTIC STRATEGY IN
ALZHEIMER S DISEASE: Ml MUSCARINIC AGONISTS IN
ALZHEIMER S DISEASE 205
Abraham Fisher, Zipora Pittel, Rachel Haring, Rachel Brandeis, Nira Bar Ner,
Hagar Sonego, Itzhak Marcovitch, Niva Natan, Nadine Mestre Frances,
and Noelle Bons
PHENSERINE REGULATES TRANSLATION OF ß AMYLOID
PRECURSOR PROTEIN MESSAGE: A NOVEL DRUG TARGET
FOR ALZHEIMER S DISEASE 211
D. K. Lahiri, T. Utsuki, K. T. Y. Shaw, Y. W. Ge, K. Sambamurti, P. S. Eder,
J. T. Rogers, M. R. Farlow, T. Giordino, and N. H. Greig
THE FORKHEAD FAMILY OF TRANSCRIPTION FACTORS ARE
TARGETS OF AKT IN IGF 1 MEDIATED SURVIVAL IN
NEURONAL CELLS 217
Wen Hua Zheng, Satyabrata Kar and Remi Quirion
CONTENTS xvii
NEW TREATMENT ON THE HORIZON IN ALZHEIMER S DISEASE
DEVELOPMENT OF ANTI DEMENTIA DRUGS FOR ALZHEIMER S
DISEASE: PRESENT AND FUTURE 223
Toshitaka Nabeshima and Kiyofumi Yamada
HUMAN NEURAL STEM CELL TRANSPLANTATION IMPROVES
COGNITIVE FUNCTION OF AGED BRAIN: POSSIBILITY OF
NEUROREPLACEMENT THERAPY 229
Kiminobu Sugaya, Tingyu Qu, Hojoong M. Kim, and Christopher L. Brannen
BiP/GRP78 INDUCED MICROGLIAL ACTIVATION AND INCREASE OF
AßCLEARANCE 235
Yoshihisa Kitamura, Jun ichi Kakimura, Takashi Taniguchi, Shun Shimohama,
and Peter J. Gebicke Haerter
PROGRESS IN PARKINSON S DISEASE
ETIOLOGY AND PATHOGENESIS
ETIOLOGY, PATHOGENESIS, AND GENETICS OF PARKINSON S
DISEASE 239
Yoshikuni Mizuno, Nobutaka Hattori, Hideki Shimura, Tohru Kitada,
Shin ichiro Kubo, Mei Wang, Ken ichi Sato, Toshiaki Suzuki,
Tomoki Chiba, Keiji Tanaka, Shuichi Asakawa, Shinsei Minoshima,
and Nobuyoshi Shimizu
PARKINSON S DISEASE, NEUROTOXINS AND THE DOPAMINE
TRANSPORTER: EVIDENCE FROM CLASSICAL BRAIN
DOPAMINE STUDIES 245
Oleh Hornykiewicz
GENETIC RISK FACTORS IN PARKINSON S DISEASE 251
Kin Lun Tsang, Zhe Hui Feng, Hong Jiang, David B. Ramsden,
and Shu Leong Ho
INFLAMMATORY CHANGES AND APOPTOSIS IN PARKINSON S
DISEASE 259
Etienne C. Hirsch
CYTOKINES AND NEUROTROPHINS IN PARKINSON S DISEASE:
INVOLVEMENT IN APOPTOSIS 265
Toshiharu Nagatsu, Makio Mogi, Hiroshi Ichinose, and Akifumi Togari
CHRONIC COMPLEX 1 INHIBITION REPRODUCES FEATURES OF
PARKINSON S DISEASE: PESTICIDES AND PARKINSON S
DISEASE 271
Todd B. Sherer, Ranjita Betarbet, and J. Timothy Greenamyre
xvüi CONTENTS
NEUTRAL (Ä)SALSOLINOL W METHYL TRANSFERASE AS A
PATHOGENIC FACTOR OF PARKINSON S DISEASE 277
Wakako Maruyama, Takako Yamada, Yukihiko Washimi, Teruhiko Kachi,
Nobuo Yanagisawa, Fujiko Ando, Hitoshi Shimokata, and Makoto Naoi
FAMILIAL PARKINSON S DISEASE
FAMILIAL VARIANTS OF PARKINSON S DISEASE 281
Katrina Gwinn Hardy, Melissa Hanson, Zbigniew Wszolek, Amanda Adam,
Andrew Singleton, Charles H. Adler, John N. Caviness, James Bower,
Steven Hickey, Judy Ying Chen, Shamaila Waseem, and Matt Fairer
FAMILIAL PARKINSONISM WITH APATHY, DEPRESSION AND
CENTRAL HYPOVENTILATION (PERRY S SYNDROME) 285
Bülent Elibol, Tomonori Kobayashi, F. Beigin Ata?, Nobutaka Hattori,
Gürdal Sahin, Günfer Gürer, and Yoshikuni Mizuno
UBIQUITIN PROTEASOME PATHWAY IS A KEY TO UNDERSTANDING
OF NIGRAL DEGENERATION IN AUTOSOMAL RECESSIVE
JUVENILE PARKINSON S DISEASE 291
Nobutaka Hattori, Shuichi Asakawa, Hideki Shimura, Shin ichiro Kubo,
Kenichi Sato, Toshiaki Kitami, Yoko Chikaoka Kawamura,Yuzuru Imai,
Ryosuke Takahashi, Toshiaki Suzuki, Keiji Tanaka, Nobuyoshi Shimizu,
and Yoshikuni Mizuno
COLOCALIZATION OF PARKIN WITH a SYNUCLEIN IN THE LEWY
BODIES OF PARKINSON DISEASE 297
Michael G. Schlossmacher, Matthew P. Frosch, Wei Ping Gai, Nutan Sharma,
Miguel Medina, Tomoyo Ochiishi, Hideki Shimura, Nobutaka Hattori,
Yoshikuni Mizuno, Bradley T. Hyman, Dennis J. Selkoe,
and Kenneth S. Kosik
UBIQUITINATION OF A NOVEL FORM OF a SYNUCLEIN BY PARKIN ... 301
Hideki Shimura, Michael G. Schlossmacher, Nobutaka Hattori,
Matthew P. Frosch, Alexander Trockenbacher, Rainer Schneider,
Yoshikuni Mizuno, Kenneth S. Kosik, and Dennis J. Selkoe
CLINICAL TOPICS IN PARKINSON S DISEASE
A SHORT HISTORY OF DOPAMINE AND LEVODOPA IN
PARKINSON S DISEASE 305
Reinhard Horowski
FAMOUS PEOPLE WITH PARKINSON DISEASE 311
Abraham Lieberman
HISTORICAL ASPECTS OF PARKINSON S DISEASE IN JAPAN 315
Kunio Tashiro
CONTENTS xix
CLINICAL EVALUATION AND DIFFERENTIAL DIAGNOSIS OF
PARKINSONISM 321
Philip D. Thompson
THE NATURAL HISTORY AND PROGNOSIS OF PARKINSON S
DISEASE 325
Werner Poewe
GAIT DISTURBANCES IN PARKINSON S DISEASE 329
Nir Giladi, Jacov Balash, and Jeffrey M. Hausdorff
LEVODOPA DOES NOT ENHANCE NIGRAL DEGENERATION 337
Ali H. Rajput
DEMENTIA IN IDIOPATHIC PARKINSON S SYNDROME 343
Heinz Reichmann and Ulrike Sommer
AUTONOMIC DISORDERS AND MALIGNANT SYNDROME IN
PARKINSON S DISEASE 349
Sadako Kuno
PROGRESS IN SEGAWA S DISEASE 353
Masaya Segawa
PROGRESS IN THE TREATMENT OF PARKINSON S DISEASE
PROGRESS IN THE TREATMENT OF PARKINSON S DISEASE 361
Donald B. Calne
THEORETICAL CONSIDERATION OF DRUG THERAPY IN
PARKINSON S DISEASE 365
Jin Soo Kim and Young H. Sohn
NEUROPROTECTION IN PARKINSON S DISEASE 373
L. V. Prasad Korlipara and Anthony H. V. Schapira
DOPAMINE AGOMSTS
SUSTAINED DOPAMINE AGONISM WITH CABERGOLINE IN
PARKINSON S DISEASE: EVOLUTION OF THERAPY
FROM AMMAL MODELS TO MAN 379
Linda S. Appiah Kubi and K. Ray Chaudhuri
SLEEPINESS AND SLEEP ATTACKS IN PARKINSON S DISEASE 385
Anette V. Nieves and Anthony E. Lang
xx CONTENTS
NEUROPROTECTION BY DOPAMINE AGONISTS AND APPLICATION
OF IMMUNOPHILIN LIGANDS 391
Tomoyoshi Kondo
MECHANISM AND TREATMENT OF MOTOR COMPLICATIONS
PROBLEMS OF LONG TERM LEVODOPA TREATMENT 397
Fabrizio Stocchi
EVALUATION OF ABNORMAL INVOLUNTARY MOVEMENTS IN
PARKINSON S DISEASE 403
Hakan Widner
MEDICAL TREATMENT OF L DOPA INDUCED DYSKINESIAS 409
Olivier Rascol, Christine Brefel Courbon, P. Payoux, and Joaquim F. Ferreira
TREATMENT OF DEPRESSION AND COGNITIVE DYSFUNCTION IN
PARKINSON S DISEASE
MANAGEMENT OF ANXIETY AND DEPRESSION IN PARKINSON S
DISEASE 417
Bhim S. Singhai, Jamshed A. Lalkaka, and Ashit Sheth
TANDOSPIRONE CITRATE, A NEW SEROTONERGIC ANXIOLYTIC
AGENT: A POTENTIAL USE IN PARKINSON S DISEASE 423
Yukihiro Ohno
SURGICAL TREATMENT OF PARKINSON S DISEASE
STEREOTACTIC SURGERY OF PARKINSON S DISEASE OVER
30YEARS 429
Chihiro Ohye
SURGICAL TREATMENT FOR DYSKINESIAS 435
Andres M. Lozano and Hazem A. Eltahawy
DEEP BRAIN STIMULATION AND NEUROPROTECTION 441
Alim Louis Benabid, Brigitte Piallat, Abdelhamid Benazzouz, Adnan Koudsie,
Stephan Chabardes, Pierre Pollak, Doris Lenartz, and Christian Andressen
NEW TREATMENT ON THE HORIZON IN PARKINSON S DISEASE
CYCLIC GMP MEDIATED PRECONDITIONING GENE INDUCTION AS A
TREATMENT OF ALZHEIMERN DEMENTIA AND
PARKINSON S DISEASE 447
Chuang Chin Chiueh and Tsugunobu Andoh
CONTENTS xxi
NEUROPROTECTIVE PROPERTIES OF GPI1046, A NON
IMMUNOSUPPRESSIVE IMMUNOPHILIN LIGAND 455
Ken ichi Tanaka and Norio Ogawa
GENE THERAPY FOR PARKINSON S DISEASE USING AAV VECTORS 459
Keiya Ozawa, Shin ichi Muramatsu, Ken ichi Fujimoto, Kunihiko Ikeguchi,
Yang Shen, Lijun Wang, Takashi Okada, Hiroaki Mizukami,
Yutaka Hanazono, Akihiro Kume, Hiroshi Ichinose, Toshiharu Nagatsu,
Keiji Terao, and Imaharu Nakano
FK506 PROTECTS DOPAMINERGIC DEGENERATION THROUGH
INDUCTION OF GDNF IN RODENT BRAINS: NEW
TREATMENTS ON THE HORIZON IN PARKINSON S DISEASE 463
Atsumi Nitta, Rina Murai, Keiko Maruyama, and Shoei Furukawa
ANTI APOPTOTIC THERAPY FOR PARKINSON S DISEASE:
OVEREXPRESSION OF AN APAF 1 DOMINANT NEGATIVE
INHIBITOR CAN BLOCK MPTP TOXICITY 469
Hideki Mochizuki, Hideki Hayakawa, Makoto Migita, Takashi Shimada,
Masayuki Miura, and Yoshikuni Mizuno
DEMENTIA WITH LEWY BODIES
CLINICAL DIAGNOSTIC CLASSIFICATION OF DEMENTIA WITH
LEWY BODIES 473
Daniel I. Kaufer
NEUROPATHOLOGY OF DEMENTIA WITH LEWY BODIES 477
Kenji Kosaka and Eizo Iseki
MOLECULAR BIOLOGY OF LEWY BODY FORMATION:
a SYNUCLEINOPATHIES 483
Maria Grazia Spillantini and George K. Tofaris
CHOLINERGIC AND MONOAMINERGIC CORRELATES OF CLINICAL
SYMPTOMS IN DEMENTIA WITH LEWY BODIES 491
Elaine K. Perry, Margaret A. Piggott, Mary Johnson, Clive G. Ballard.
Ian G. McKeith, Evelyn Jaros, and Robert H. Perry
MOLECULAR BIOLOGY OF ct SYNUCLEIN: DEMENTIA WITH LEWY
BODIES 497
Olaf Riess, Rejko Krüger, Hirokazu Kobayashi, Carsten Holzmann,
Nobutaka Hattori, and Yoshikuni Mizuno
ACCUMULATION OF INSOLUBLE a SYNUCLEIN IN HUMAN LEWY
BODY DISEASES IS RECAPITULATED IN TRANSGENIC MICE.... 509
Philipp J. Kahle, Manuela Neumann, Laurence Ozmen, Takeshi Iwatsubo,
Hans A. Kretzschmar, and Christian Haass
xxii CONTENTS
ALTERNATIVE TREATMENTS FOR LEWY BODY DISEASE IN
TRANSGENIC MICE: DEMENTIA WITH LEWY BODIES 513
Manfred Windisch, Edward Rockenstein, Makoto Hashimoto.
Margaret Mallory, and Eliezer Masliah
FAMILIAL FRONTOTEMPORAL DEMENTIA AND RELATED DISORDERS
FAMILIAL FRONTOTEMPORAL DEMENTIA AND PARKINSONISM
(FTDP 17): A CONSENSUS ON CLINICAL DIAGNOSTIC
CRITERIA 517
Zbigniew K. Wszolek and Yoshio Tsuboi
THE NEUROPATHOLOGY OF FRONTOTEMPORAL LOBAR
DEGENERATION 523
David M. A. Mann and Stuart M. Pickering Brown
PROGRESS IN PSP AND CBD 531
D. W. Dickson, K. Ishizawa, T. Togo, M. Baker, J. Adamson, M. Hutton,
W. K. Liu, and S. H. Yen
BIOCHEMICAL ANALYSIS OF TAU AND a SYNUCLEIN IN
NEURODEGENERATIVE DISEASES 537
Masato Hasegawa, Sayuri Taniguchi, Hirofumi Aoyagi, Hideo Fujiwara,
and Takeshi Iwatsubo
PRODUCTION AND ANALYSIS OF HUMAN MUTANT TAU (V337M)
TRANSGENIC MOUSE 543
Akihiko Takashima and Kentaro Tanemura
INDEX 549
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV014760651 |
| callnumber-first | R - Medicine |
| callnumber-label | RC523 |
| callnumber-raw | RC523 |
| callnumber-search | RC523 |
| callnumber-sort | RC 3523 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YG 4005 |
| ctrlnum | (OCoLC)248474500 (DE-599)BVBBV014760651 |
| dewey-full | 616.831 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.831 |
| dewey-search | 616.831 |
| dewey-sort | 3616.831 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01980nam a2200457 cb4500</leader><controlfield tag="001">BV014760651</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20030506 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">020926s2002 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0306467631</subfield><subfield code="9">0-306-46763-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)248474500</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014760651</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC523</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.831</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 4005</subfield><subfield code="0">(DE-625)153494:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Mapping the progress of Alzheimerś and Parkinsonś disease</subfield><subfield code="b">[proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan]</subfield><subfield code="c">ed. by Yoshikuno Mizuno ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Kluwer Academic/Plenum Publ.</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXII, 565 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Advances in behavioral biology</subfield><subfield code="v">51</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alzheimer Disease</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alzheimer's disease</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson Disease</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parkinson's disease</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2001</subfield><subfield code="z">Kioto</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mizuno, Yoshikuni</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Advances in behavioral biology</subfield><subfield code="v">51</subfield><subfield code="w">(DE-604)BV000006474</subfield><subfield code="9">51</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009995095&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009995095</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2001 Kioto gnd-content |
| genre_facet | Konferenzschrift 2001 Kioto |
| id | DE-604.BV014760651 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:05:53Z |
| institution | BVB |
| isbn | 0306467631 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009995095 |
| oclc_num | 248474500 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 |
| owner_facet | DE-355 DE-BY-UBR DE-12 |
| physical | XXII, 565 S. Ill., graph. Darst. |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Kluwer Academic/Plenum Publ. |
| record_format | marc |
| series | Advances in behavioral biology |
| series2 | Advances in behavioral biology |
| spelling | Mapping the progress of Alzheimerś and Parkinsonś disease [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] ed. by Yoshikuno Mizuno ... New York [u.a.] Kluwer Academic/Plenum Publ. 2002 XXII, 565 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Advances in behavioral biology 51 Alzheimer Disease Congresses Alzheimer's disease Congresses Parkinson Disease Congresses Parkinson's disease Congresses Alzheimerkrankheit (DE-588)4112510-1 gnd rswk-swf Parkinson-Krankheit (DE-588)4044683-9 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2001 Kioto gnd-content Parkinson-Krankheit (DE-588)4044683-9 s DE-604 Alzheimerkrankheit (DE-588)4112510-1 s Mizuno, Yoshikuni Sonstige oth Advances in behavioral biology 51 (DE-604)BV000006474 51 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009995095&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Mapping the progress of Alzheimerś and Parkinsonś disease [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] Advances in behavioral biology Alzheimer Disease Congresses Alzheimer's disease Congresses Parkinson Disease Congresses Parkinson's disease Congresses Alzheimerkrankheit (DE-588)4112510-1 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd |
| subject_GND | (DE-588)4112510-1 (DE-588)4044683-9 (DE-588)1071861417 |
| title | Mapping the progress of Alzheimerś and Parkinsonś disease [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] |
| title_auth | Mapping the progress of Alzheimerś and Parkinsonś disease [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] |
| title_exact_search | Mapping the progress of Alzheimerś and Parkinsonś disease [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] |
| title_full | Mapping the progress of Alzheimerś and Parkinsonś disease [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] ed. by Yoshikuno Mizuno ... |
| title_fullStr | Mapping the progress of Alzheimerś and Parkinsonś disease [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] ed. by Yoshikuno Mizuno ... |
| title_full_unstemmed | Mapping the progress of Alzheimerś and Parkinsonś disease [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] ed. by Yoshikuno Mizuno ... |
| title_short | Mapping the progress of Alzheimerś and Parkinsonś disease |
| title_sort | mapping the progress of alzheimers and parkinsons disease proceedings of the 5th international conference on the progress in alzheimer s and parkinson s disease held from march 31st to april 5th 2001 in kyoto japan |
| title_sub | [proceedings of the 5th International Conference on the progress in Alzheimer's and Parkinson's disease, held from march 31st to april 5th, 2001, in Kyoto, Japan] |
| topic | Alzheimer Disease Congresses Alzheimer's disease Congresses Parkinson Disease Congresses Parkinson's disease Congresses Alzheimerkrankheit (DE-588)4112510-1 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd |
| topic_facet | Alzheimer Disease Congresses Alzheimer's disease Congresses Parkinson Disease Congresses Parkinson's disease Congresses Alzheimerkrankheit Parkinson-Krankheit Konferenzschrift 2001 Kioto |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009995095&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000006474 |
| work_keys_str_mv | AT mizunoyoshikuni mappingtheprogressofalzheimersandparkinsonsdiseaseproceedingsofthe5thinternationalconferenceontheprogressinalzheimersandparkinsonsdiseaseheldfrommarch31sttoapril5th2001inkyotojapan |